| KCNK16 Protein | |
|---|---|
| Protein Name | Potassium Two Pore Domain Channel Subfamily K Member 16 |
| Gene | [KCNK16](/genes/kcnk16) |
| UniProt ID | [Q96PS8](https://www.uniprot.org/uniprot/Q96ps8) |
| Molecular Weight | ~38 kDa |
| Subcellular Localization | Cell membrane |
| Protein Family | K2P channel family (TALK subfamily) |
| Channel Type | Two-pore domain potassium channel |
| Ion Selectivity | K+ selective |
KCNK16 (Potassium Two Pore Domain Channel Subfamily K Member 16), also known as TASK-5 or TALK-1, is a member of the two-pore domain (K2P) potassium channel family. Unlike other K2P family members, KCNK16 exhibits several unique properties including its expression pattern, pH sensitivity, and potential roles in secretory epithelia [1]. The channel contributes to background potassium conductance that maintains the resting membrane potential in various cell types, particularly in epithelial cells of secretory glands [2]. [1]
The TALK (TWIK-related alkaline pH-activated K+ channel) subfamily includes KCNK16 (TALK-1), KCNK17 (TALK-2), and KCNK10 (TALK-3) [3]. These channels share structural features and regulatory mechanisms but exhibit distinct tissue distributions and biophysical properties. KCNK16 is notably expressed at high levels in salivary glands, pancreas, and other exocrine tissues, suggesting specialized functions in fluid and electrolyte secretion [4]. [2]
KCNK16 shares the characteristic architecture of K2P channels, with four transmembrane helices (M1-M4) and two pore domains (P1 and P2) arranged in tandem [5]. The channel forms homodimers, with each subunit contributing two transmembrane segments and one pore domain to create the functional channel [6]. [3]
Key structural features include: [4]
KCNK16 has several distinctive structural characteristics compared to other TALK family members: [5]
Like other K2P channels, KCNK16 contributes to the resting membrane potential through background potassium conductance [7]. This function is particularly important in epithelial cells where membrane potential affects ion transport and fluid secretion [8]. [6]
KCNK16 is highly expressed in salivary glands, where it plays a crucial role in saliva production [9]. The channel contributes to: [7]
In the pancreas, KCNK16 is expressed in pancreatic ductal epithelial cells and potentially beta-cells [10]. Its roles may include:
KCNK16 exhibits sensitivity to extracellular pH, though with different characteristics from KCNK17 [11]. The channel shows:
KCNK16 expression is concentrated in secretory epithelia:
While KCNK16 is primarily studied in the context of epithelial secretion, several potential links to neurological function have been proposed:
Patients with neurodegenerative diseases, particularly Parkinson's disease, commonly experience xerostomia (dry mouth) as a non-motor symptom [12]. This may relate to:
KCNK16 dysfunction could theoretically contribute to salivary gland dysfunction in these patients, though direct evidence is lacking [13].
Emerging evidence links pancreatic dysfunction to neurodegenerative diseases [14]. Type 2 diabetes and metabolic syndrome are risk factors for Alzheimer's disease and Parkinson's disease [15]. KCNK16 in the pancreas may play roles in:
Although KCNK16 mutations have not been directly linked to human neurological disease, potassium channelopathies increasingly recognized in neurology [16]. Conditions such as episodic ataxia, neonatal seizures, and certain forms of epilepsy result from potassium channel mutations [17].
KCNK16 may be a therapeutic target for Sjögren's syndrome, an autoimmune disorder causing dry mouth and dry eyes [18]. Understanding KCNK16 function could lead to:
Given KCNK16's expression in the pancreas, channel modulators might affect:
Selective KCNK16 modulators remain under development [19]. Potential therapeutic applications include:
Standard techniques for studying KCNK16 include:
Key biophysical properties:
KCNK16 interacts with various cellular proteins:
KCNK16 is a two-pore domain potassium channel with high expression in secretory epithelia, particularly salivary glands and pancreas. While not directly implicated in neurodegenerative diseases, its roles in epithelial secretion may have implications for non-motor symptoms in conditions like Parkinson's disease. Further research is needed to characterize KCNK16's functions in both peripheral tissues and the nervous system.
Miklossy, J. et al. Type 3 diabetes and neurodegeneration (2006). 2006. ↩︎
Mattson, M.P. et al. Metabolism and neurodegeneration (2007). 2007. ↩︎
Shalaby, L.Y. et al. Potassium channelopathies (2009). 2009. ↩︎
Pongs, O. & Schwarz, J.R., Potassium channel diseases affecting neurons (2010). 2010. ↩︎
Fox, P.C. et al. Sjögren's syndrome (2001). 2001. ↩︎
Baron, M. & L. B., K2P channel drug development (2013). 2013. ↩︎
Rajan, S. et al. 14-3-3 proteins and K2P channel trafficking (2005). 2005. ↩︎